These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [MTP inhibitors and ACAT inhibitors. An update]. Ohashi K Nihon Rinsho; 2002 May; 60(5):975-83. PubMed ID: 12030002 [TBL] [Abstract][Full Text] [Related]
7. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
8. Therapies on the horizon for cholesterol reduction. Brown WV Clin Cardiol; 2001 Aug; 24(8 Suppl):III24-7. PubMed ID: 11501600 [TBL] [Abstract][Full Text] [Related]
9. Lipid-altering agents: the future. Wierzbicki AS Int J Clin Pract; 2004 Nov; 58(11):1063-72. PubMed ID: 15605675 [TBL] [Abstract][Full Text] [Related]
10. Novel agents to manage dyslipidemias and impact atherosclerosis. Nachimuthu S; Raggi P Cardiovasc Hematol Disord Drug Targets; 2006 Sep; 6(3):209-17. PubMed ID: 17017903 [TBL] [Abstract][Full Text] [Related]
11. What future for combination therapies? Kastelein J Int J Clin Pract Suppl; 2003 Mar; (134):45-50. PubMed ID: 12793597 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia. Sudhop T; von Bergmann K Drugs; 2002; 62(16):2333-47. PubMed ID: 12396226 [TBL] [Abstract][Full Text] [Related]